Related Experiment Videos
Familial infantile myasthenia.
Archives of Neurology
|February 1, 1980
Summary
Familial infantile myasthenia is a rare genetic disorder causing infant respiratory depression and weakness. Early diagnosis and treatment with anticholinesterase medication are crucial for managing this condition.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Familial infantile myasthenia is a rare neuromuscular disorder.
- It is characterized by respiratory depression and episodic weakness in infants.
Observation:
- The condition presents with absence of myasthenia in the mother.
- Affected infants exhibit respiratory depression at birth, episodic weakness, and apnea within the first two years.
- A similar disorder is observed among siblings, and symptoms improve with age.
Findings:
- Familial infantile myasthenia is a distinct subtype of myasthenia grauci.
- Key diagnostic features include a family history, respiratory distress at birth, and fluctuating weakness.
Implications:
- Early diagnosis is vital as the condition responds to anticholinesterase medication.
- This disorder is a potential cause of sudden infant death and should be considered in cases of unexplained respiratory distress.